Alliance Pharma plc Company Profile (LON:APH)

About Alliance Pharma plc (LON:APH)

Alliance Pharma plc logoAlliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

Industry, Sector and Symbol: Capitalization:
  • Market Cap: £279.01 million
  • Outstanding Shares: 472,899,000
Average Prices:
  • 50 Day Moving Avg: GBX 54.59
  • 200 Day Moving Avg: GBX 52.01
  • 52 Week Range: GBX 41.33 - GBX 60
  • Trailing P/E Ratio: 12.83
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £101.43 million
  • Price / Sales: 2.75
  • Book Value: GBX 0.40 per share
  • Price / Book: 1.48
  • EBITDA: £26.4 million
  • Net Margins: 26.73%
  • Return on Equity: 14.63%
  • Return on Assets: 8.39%
  • Average Volume: 727,635 shs.

Frequently Asked Questions for Alliance Pharma plc (LON:APH)

What is Alliance Pharma plc's stock symbol?

Alliance Pharma plc trades on the London Stock Exchange (LON) under the ticker symbol "APH."

How often does Alliance Pharma plc pay dividends? What is the dividend yield for Alliance Pharma plc?

Alliance Pharma plc declared a dividend on Wednesday, September 13th. Investors of record on Thursday, December 21st will be given a dividend of GBX 0.44 per share on Thursday, January 11th. This represents a yield of 0.84%. The ex-dividend date is Thursday, December 21st. The official announcement can be seen at this link. View Alliance Pharma plc's Dividend History.

Where is Alliance Pharma plc's stock going? Where will Alliance Pharma plc's stock price be in 2017?

3 brokerages have issued 12-month price objectives for Alliance Pharma plc's shares. Their forecasts range from GBX 58 to GBX 60. On average, they expect Alliance Pharma plc's share price to reach GBX 59 in the next twelve months. View Analyst Ratings for Alliance Pharma plc.

Who are some of Alliance Pharma plc's key competitors?

Who are Alliance Pharma plc's key executives?

Alliance Pharma plc's management team includes the folowing people:

  • John Dawson, Chief Executive Officer, Executive Director
  • Andrew Franklin, Finance Director, Director
  • Peter Butterfield, Chief Commercial Officer, Executive Director
  • Janice Timberlake, Director of Human Resources
  • Margaret Boulton, Medical and Regulatory Affairs Director
  • Stephen Kidner, Operations Director
  • Dan Thomas, Business Development Director
  • Sarah Robinson, Company Secretary
  • Andrew L. Smith, Non-Executive Chairman of the Board
  • Thomas Theodore Casdagli, Non-Executive Director

How do I buy Alliance Pharma plc stock?

Shares of Alliance Pharma plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Alliance Pharma plc's stock price today?

One share of Alliance Pharma plc stock can currently be purchased for approximately GBX 59.

MarketBeat Community Rating for Alliance Pharma plc (LON APH)
Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  84 (Vote Outperform)
Underperform Votes:  150 (Vote Underperform)
Total Votes:  234
MarketBeat's community ratings are surveys of what our community members think about Alliance Pharma plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Alliance Pharma plc (LON:APH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 59
Consensus Price Target History for Alliance Pharma plc (LON:APH)
Price Target History for Alliance Pharma plc (LON:APH)
Analysts' Ratings History for Alliance Pharma plc (LON:APH)
DateFirmActionRatingPrice TargetDetails
9/14/2017FinnCapReiterated RatingBuyGBX 58View Rating Details
9/13/2017N+1 SingerReiterated Ratingnot ratedView Rating Details
9/13/2017InvestecInitiated CoverageBuyGBX 59View Rating Details
9/13/2017Numis Securities LtdReiterated RatingBuyGBX 60View Rating Details
(Data available from 10/20/2015 forward)


Earnings History for Alliance Pharma plc (LON:APH)
No earnings announcements for this company have been tracked by


Earnings Estimates for Alliance Pharma plc (LON:APH)
Current Year EPS Consensus Estimate: $4.00 EPS


Dividend History by Quarter for Alliance Pharma plc (LON APH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/13/2017GBX 0.440.84%12/21/201712/21/20171/11/2018
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Alliance Pharma plc (LON:APH)
Insider Trades by Quarter for Alliance Pharma plc (LON:APH)
Insider Trades by Quarter for Alliance Pharma plc (LON:APH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/14/2017Peter ButterfieldInsiderSell61,846GBX 49£30,304.54
9/22/2016John DawsonInsiderSell3,000,000GBX 45£1,350,000
5/3/2016Cook,DavidInsiderBuy54,492GBX 47£25,611.24
12/22/2015Clifford,NigelInsiderBuy66,740GBX 45£30,033
12/17/2015Smith,Andrew LInsiderBuy75,000GBX 41£30,750
6/23/2015Booley,TonyInsiderSell1,155,000GBX 0.37£4,273.50
6/16/2015Nigel CliffordInsiderBuy58,227GBX 39.50£22,999.67
(Data available from 1/1/2013 forward)


Headline Trends for Alliance Pharma plc (LON:APH)
Latest Headlines for Alliance Pharma plc (LON:APH)
DateHeadline logoAlliance Pharma Plc :APH-GB: Earnings Analysis: For the six months ended June 30, 2017 : September 29, 2017 - October 2 at 3:48 PM logoNumis Securities Ltd Reaffirms "Buy" Rating for Alliance Pharma plc (APH) - September 17 at 2:08 PM logoN+1 Singer Reaffirms not rated Rating for Alliance Pharma plc (APH) - September 13 at 11:06 AM logoAlliance Pharma plc (APH) Research Coverage Started at Investec - September 13 at 8:05 AM logoAlliance Pharma Plc – Value Analysis (LONDON:APH) : September 7, 2017 - September 7 at 3:57 PM logoAlliance Pharma Plc breached its 50 day moving average in a Bullish Manner : APH-GB : September 6, 2017 - September 6 at 3:53 PM logoAlliance Pharma plc (APH) Set to Announce Earnings on Wednesday - September 6 at 1:46 AM logoFinnCap Reaffirms Buy Rating for Alliance Pharma plc (APH) - August 28 at 5:02 PM logoUpdate on Diclectin - London South East (registration) (blog) - July 29 at 3:41 PM logo2 terrific value stocks I’d buy today - July 20 at 5:19 PM logoAlliance Pharma says Europe move a Brexit shield - March 29 at 3:46 PM logoApplication for admission - Regulatory News, RNS - London South ... - London South East (registration) (blog) - February 14 at 9:13 PM logoPDMR shareholding - London South East (registration) (blog) - February 14 at 4:13 PM logoCapital Markets Event - London South East (registration) (blog) - December 8 at 3:49 PM logo[$$] Investec director pockets £11m - October 7 at 3:31 PM logoAlliance Pharma posts 113% jump in 1H profit - September 15 at 12:26 PM logoHalf Year 2016 Alliance Pharma PLC Earnings Release - Before Market Open - September 14 at 7:53 AM logo3 hot dates for your September investment diaries - September 1 at 11:59 AM


Social activity is not available for this stock.


Alliance Pharma plc (APH) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.